Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclomethasone for PASC Hyposmia
NCT05970731Phase 2Completed
- Sponsor
- Duke University
- Start
- Sep 2023
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of beclomethasone in Hyposmia, sponsored by Duke University. Started Sep 2023; status: completed.
02
Drugs
beclomethasone
03
Conditions
Hyposmia
Beyond the preview
Go deeper on NCT05970731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05970731.